This inventor holds 1 USPTO granted patent. Top assignee: Deutsches Krebsforschungszentrum Stiftung Des Offentlichen Rechts. Active years: 2004.
Company Filing History:
Years Active: 2004
Title: Innovations of Marcus Peter in Apoptosis Regulation
Introduction
Marcus Peter is a notable inventor based in Heidelberg, Germany. He has made significant contributions to the field of apoptosis regulation through his innovative research and inventions. His work focuses on the development of proteins and nucleic acids that play a crucial role in the regulation of cell death.
Latest Patents
Marcus Peter holds a patent for "Mutant DEDD proteins for regulating apoptosis." This invention relates to a protein that is instrumental in regulating apoptosis, as well as a nucleic acid encoding the protein. The protein and nucleic acids are valuable in diagnosing or detecting apoptosis. Additionally, the invention includes antibodies directed against the protein. He has 1 patent to his name.
Career Highlights
Marcus Peter is affiliated with the Deutsches Krebsforschungszentrum Stiftung Des Öffentlichen Rechts, where he conducts his research. His work has been pivotal in advancing our understanding of apoptosis and its implications in various biological processes.
Collaborations
One of his notable collaborators is Peter Krammer, with whom he has worked on various projects related to apoptosis and cancer research.
Conclusion
Marcus Peter's innovative contributions to the field of apoptosis regulation highlight the importance of his research in understanding cell death mechanisms. His work continues to influence the scientific community and pave the way for future advancements in this critical area of study.